-
Healthcare stocks stay active despite a softer week
24 Oct 2025 04:43 GMT
… prescriptions.
Supported by the US Biomedical Advanced Research and Development Authority (BARDA), the study will …
-
GSK & Spero announce positive PIVOT-PO phase III trial of tebipenem HBr, an investigational oral treatment for complicated urinary tract infections
22 Oct 2025 12:40 GMT
… for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under contract number …
-
Appili Therapeutics to Attend BARDA Innovation Symposium 2025
22 Oct 2025 11:20 GMT
… that it will attend the Biomedical Advanced Research and Development Authority (BARDA) Innovation Symposium on … .S. agencies such as the Biomedical Advanced Research and Development Authority (BARDA), reflects the growing …
-
LDX starts FebriDx CLIA-waiver study
22 Oct 2025 05:37 GMT
… being supported by the US Biomedical Advanced Research and Development Authority (BARDA).
It will evaluate …
-
Lumos Diagnostics launches US pediatric study for FebriDx® in...
22 Oct 2025 02:05 GMT
… of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA), part of the … and Response (ASPR) and the Biomedical Advanced Research and Development Authority (BARDA).
Lumos partners with …
-
Positive PIVOT-PO phase III data show tebipenem HBr’s potential as the first oral carbapenem antibiotic for patients with complicated urinary tract infections (cUTIs)
21 Oct 2025 06:22 GMT
… for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under contract number …
-
PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
21 Oct 2025 06:00 GMT
… for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under contract number …
-
True Diagnostics Awarded BARDA RRPV Project to Advance Rapid Biothreat Test
20 Oct 2025 15:00 GMT
… a Consortium funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the … Strategic Preparedness and Response (ASPR); Biomedical Advanced Research and Development Authority (BARDA), under Other Transaction …
-
Cell and Gene Solutions Market Trends and Growth – A Comprehensive Report by Towards Healthcare
20 Oct 2025 14:00 GMT
… manufacturing activities of CGTs. The Biomedical Advanced Research and Development Authority (BARDA) granted $500 million …
-
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at IDWeek 2025 and CHEST 2025
17 Oct 2025 11:30 GMT
… for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA) under contract number … for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA) under contract number …
About
© 1995-2025